Expression of concern
Fibrauretine reduces ischemia/reperfusion injury via RISK/eNOS activation
Paper Information
Record ID:
24741
Author(s):
Journal:
Publication Date:
December 03, 2019
Retraction Date:
May 29, 2020
(5.5 years years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Springer
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1007/s00210-019-01770-8Citations (3)
3
Total Citations2
Post-Retraction(66.7%)
0
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
720
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Advances in research on the protective mechanisms of traditional Chinese medicine (TCM) in myocardial ischaemia-reperfusion injury
Jiexin Zhang, Yonghe Hu, Han Wang et al. (12 authors)
Pharmaceutical Biology
Open Access
Published: May 2022
5 citations
5 citations
720 days after retraction
Retraction Note: Fibrauretine reduces ischemia/reperfusion injury via RISK/eNOS activation
Chunsheng Wang, Rong Chang, Gan Gao et al. (5 authors)
Naunyn-Schmiedeberg s Archives of Pharmacology
Open Access
Published: Dec 2020
193 days after retraction
Related Records
This article has multiple records in the database due to different notices:
Record #24740
Dec 08, 2020Quick Stats
Total Citations:
3
Years Since Retraction:
5.5 years
Open Access:
Yes
Last Checked:
Jul 24, 2025